As well as neurological manifestations, other abnormalities, particularly cardiovascular symptoms and lung diseases, especially pulmonary hypertension, are also common in patients with FLNA mutations (Bandaru et al., 2021). The gene discussed is FLNA; the disease is pulmonary arterial hypertension.